Diabetes vaccine nears decisive trial – could enable early submission

Within the coming few months, Swedish biotech firm Diamyd Medical will receive intermediate phase trial data on an experimental vaccine against type 1 diabetes. A Danish doctor says the matter is "extremely interesting."

Photo: Diamyd Medical / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles